BridgeMD

Sign in

Interaction clinical trials

Explore recruiting interaction clinical trials.

Recruiting interaction studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Interaction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in patients at high risk of postoperative pulmonary complications

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomised open-label pilot Study on Thiamine supplementation to REduce braiN injury associated with chronic Alcohol use in outpatients with alcohol use disorder : STRENA

France

Therapeutic exploratory (Phase II) EU CTIS Study details

EEG-MRI Study of the Effect of Methylphenidate on Neural Mechanisms in Adult Patients With ADHD With or Without Mood Disorders: a Randomized Controlled Trial Versus Placebo

France

Phase II and Phase III (Integrated) EU CTIS Study details

Rivaroxaban sotorasib interaction study (the ROSIE-study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

ATLANTIS Protamine - Antagonization of heparin with protamine sulfate to reduce all neurologic ischemic and hemorrhagic events after transcatheter aortic valve implantation for aortic stenosis: the ATLANTIS Protamine study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

BEVERLY: A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with EGFR mutated advanced non squamous non small cell lung cancer

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Interaction trials by city

Interaction in Toronto Interaction in Vancouver Interaction in Montreal Interaction in Calgary Interaction in Edmonton Interaction in Ottawa Interaction in Winnipeg Interaction in Quebec City Interaction in Hamilton Interaction in Kitchener Interaction in London Interaction in Halifax Interaction in New York Interaction in Los Angeles Interaction in Chicago Interaction in Houston